In a recent set of clinical trials announced by the Alzheimer’s Association, it was found that a new drug showed great promise in reducing the cognitive decline caused by Alzheimer’s disease. This drug, Lecanemab, has supposedly shown excellent results in treating the underlying causes of Alzheimer’s, and could potentially help people with the disease to live longer and healthier lives. However, more testing still needs to be performed to ensure the drug is safe and effective for public use.
Continue reading “New Alzheimer’s Drug Shows Promising Results in Testing”